Chicken Pox Info
Sunday, January 29, 2023
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
Chicken Pox Info
No Result
View All Result
Home Monkeypox

Monkeypox outbreak slowing in the US, but health leaders say critical challenges remain

Chickenpox Info by Chickenpox Info
September 13, 2022
in Monkeypox
0
Monkeypox outbreak slowing in the US, but health leaders say critical challenges remain
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.




CNN
 — 

New monkeypox cases in the United States have been steadily dropping in recent weeks, with cases reported in the first week of September cut to about half of what they were at their peak a month ago.

But the recent death of a Los Angeles County resident – the first attributed to monkeypox in the US – is a tragic reminder that the outbreak is ongoing and still poses risks.

“There is some hope around these cases leveling off. That should not be anybody’s solace that this outbreak is done,” David Harvey, executive director of the National Coalition of STD Directors, said at a briefing Tuesday.

“We still have to ramp up our efforts to respond to this outbreak. And there are many, many data questions, clinical care questions, research questions that remain to be answered about this very unusual outbreak of a known virus over the decades that is presenting itself very differently in the United States.”

Deaths from monkeypox are extremely rare and often affect babies, pregnant women and people with weakened immune systems, such as from HIV. This year, the World Health Organization has reported 22 deaths among about 58,000 cases. About 22,000 of those cases have been reported in the US.

“Back in July, CDC estimated that it took eight days for cases to double nationwide. By mid-August, the doubling rate was 25 days, showing encouraging signs of progress,” Dr. Demetre Daskalakis, the White House’s assistant monkeypox response coordinator, said last week.

But Harvey and other public health leaders warned Tuesday that people on the front lines of the response – including local health departments, epidemiologists and clinics that deal with sexually transmitted infections – do not have adequate resources to ensure continued improvement.

And there is a “very important immunocompromised population in the United States” who will be at high risk if the outbreak continues, Dr. Cesar Arias, a board member of the Infectious Disease Society of America and chief of infectious diseases at Houston Methodist Hospital, said at the briefing.

Other key areas of concern cited by US public health leaders at Tuesday’s briefing include inequitable vaccination, access to testing and incomplete surveillance data.

They called on Congress to make significant funding immediately available to address the outbreak, defending the Biden administration’s request that about $4 billion in funding be allocated to the monkeypox response in the next government funding bill as one of “four critical needs,” along with support for Ukraine, Covid-19 response and natural disaster recovery.

The push for funding comes a day before federal leaders – including US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky and National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci – are scheduled to speak to the Senate Committee on Health, Education, Labor and Pensions about the federal response to the monkeypox outbreak.

Public health leaders attribute the slowing rate of new cases to vaccination and behavior changes among those most at-risk. Men who have sex with men have been disproportionately affected in the outbreak, and about half have reported taking steps to protect themselves and their partners, according to the CDC.

But for the hopeful trend to continue, continued work and investment is needed – especially in reaching underrepresented groups, health leaders say.

“In many ways, the initial and easy work has been done. Now, local health departments are needing to be more creative, to reach more deeply into their communities hardest to reach with messaging, education, vaccine, testing and treatment,” said Lori Tremmel Freeman, chief executive officer of the National Association of County and City Health Officials.

Data from the CDC shows that people of color make up a disproportionate share of cases but are underrepresented among those vaccinated.

More than half of new monkeypox cases over the past two months have been among Black and Hispanic people, but only about a third of first vaccine doses have gone to individuals in these groups, according to a CNN analysis of CDC data.

The White House Monkeypox Response Team addressed these inequities last month, highlighting efforts to offer vaccinations at large-scale events and festivals as one strategy to curb them.

“With supply of vaccine increasing, I think we have a new opportunity in strategy which is bringing vaccine to people as opposed to trying to have people find vaccines,” Daskalakis said.

Last week, Daskalakis noted that case rates were slowing in parts of the country that have been hardest-hit, including New York, Texas, California and Illinois.

But local public health leaders emphasized the need for a broader perspective.

“We cannot take our foot off the gas simply because major cities have the means to mount a robust response, leaving smaller rural communities to fend for themselves,” Harvey said.

ShareTweetPin
Chickenpox Info

Chickenpox Info

Related Posts

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

by Chickenpox Info
January 27, 2023
0

Pharmacists should consider 2 critical safety issues when treating or vaccinating patients for monkeypox.First, it is vital to understand that...

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

by Chickenpox Info
January 27, 2023
0

Future Market Insights Global and Consulting Pvt. Ltd.Asia Pacific Monkeypox Treatment Market is projected to witness the fastest growth of...

Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

by Chickenpox Info
January 27, 2023
0

DUBAI, United Arab Emirates, Jan. 26, 2023 (GLOBE NEWSWIRE) -- A recent Future Market Insights report on the monkeypox treatment...

Florida Health Orange County

DOH-Orange MPOX / Monkeypox Vaccination Update #12

by Chickenpox Info
January 26, 2023
0

Contact: Kent Donahue Kent.Donahue@flhealth.gov407-858-1418  ORLANDO, FL – The following update is provided to keep the community informed on the Florida Department...

Study: Clinical Testing of Pediatric Mpox Specimens: Unique Features and Challenges in a Low Prevalence Population. Image Credit: Dotted Yeti / Shutterstock

An evaluation of pediatric Mpox specimens

by Chickenpox Info
January 25, 2023
0

In a recent study posted to the medRxiv* preprint server, researchers in the United States performed the clinical evaluation of...

Next Post
Outer Cape Health Services Chief Medical Officer Andrew Jorgensen

Monkeypox in Provincetown: here's an update

Lumpy Skin Disease has killed over 67000 animals in the country according to Central government (Hindustan Times)

Lumpy skin disease: Maharashtra starts vaccination, 43 animals died due to virus

RECOMMENDED

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

January 27, 2023
Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

January 27, 2023

MOST VIEWED

  • Can you catch chickenpox twice? How contagious is virus and symptoms explained

    How long does chickenpox last? When do symptoms go away, how long is it contagious – and is there treatment

    0 shares
    Share 0 Tweet 0
  • What happened to monkeypox? Answers to your most pressing questions.

    0 shares
    Share 0 Tweet 0
  • TikTok craze of using calamine lotion as makeup causing chickenpox treatment shortages, pharmacy warns

    0 shares
    Share 0 Tweet 0
  • Research finds link between chickenpox and Alzheimer’s

    0 shares
    Share 0 Tweet 0
  • Can monkeypox spread through contaminated food?

    0 shares
    Share 0 Tweet 0

Chicken Pox Info

Welcome to Chicken Pox Info, where you will get all the latest news about all the different pox diseases, to stay up to date, and to protect yourself.

CATEGORY

  • Chickenpox
  • Cowpox
  • Goatpox
  • Horsepox
  • Monkeypox
  • Sheeppox
  • Squirrelpox

Site Links

  • Home
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

Latest News

  • Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox
  • Global Monkeypox Treatment Market to reach US$ 249 million
  • Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

What Are Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT